← Eichor
Study identifier: NCT04873258 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease

Condition: Healthy · Fatty Liver · MASLD  ·  Sponsor: Richmond Research Institute

PhaseN/A
Planned participants2000
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersYes

About this study

A generic screening study to establish structural and/or functional baselines of specific organs.

This description comes directly from the study's public registry record.

Talk to the study team

James Rickard  ·  +44 (0)20 7042 5800  ·  grants@richmondresearchinstitute.org

Always discuss trial participation with your own doctor first.

Locations (1)

Richmond Pharmacology Ltd. 1a Newcomen St, London BridgeLondon, London, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04873258